How gene therapy device could create personalised medicines for rare diseases
A new portable gene therapy device could allow hospital pharmacies to create personalised medicines on demand, a new study says.
Rare diseases affect more than 300 million people worldwide - 36 million in the EU alone - but they are often overlooked due to low patient numbers and the high costs associated with drug development.
Most medicines are made in factories and shipped to hospitals, but for rare conditions there often aren't enough patients for companies to justify developing medicines in bulk.
But the NANOSPRESSO project could allow pharmacists to create medicines for them on demand, according to a paper published in Frontiers in Science.
A pharmacist using the machine would put ingredients (such as genetic material and fats) into a small cartridge, which the device then mixes together in a very precise way. A tiny, targeted medicine can then be injected into the patient.
Prof Raymond Schiffelers, who led the project, said there is an "urgent need" for a way to make personalised medicines in hospitals and on demand in an affordable way.
"By shifting production to the point of care, NANOSPRESSO could help bring life-changing precision medicines within reach of patients."
However, NANOSPRESSO faces significant hurdles before it can be seen in a healthcare setting anytime soon.
The medicines it creates will need to meet strict safety and quality standards, and regulators will need to decide how they will approve and monitor individualised treatments.
"NANOSPRESSO could revolutionise the way we treat rare diseases by bringing personalised medicine to more patients, faster," says study author Dr Mariona Estapé Senti.
"The user-friendly, affordable device could let medics treat conditions that conventional approaches can't manage."
The study cites a historical precedent for pharmacies producing medicines - until the 20th century, pharmacists routinely prepared tailored medicines by hand.
They also cite the success of using similar nucleic acid platforms to produce mRNA vaccines during the COVID-19 pandemic, and say that modern advancements in closed-system microfluidics have enabled such breakthroughs such as this.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
29 minutes ago
- Daily Mail
America becomes cancer capital of the WORLD with more cases than all but one country
America has surpassed all but one country in new cancer diagnoses, making it a cancer capital of the world. The US saw 2.4million new cases of cancer in 2022, surpassing all but China, which saw nearly 4.8million. However, the US saw a higher rate than the Asian country - 1,307 cases per 100,000 people, compared to China's 490 per 100,000. Overall, the US has the fifth-highest cancer rate in the world, and cases are climbing. America made up about 13 percent of the 19 million cases recorded worldwide in 2022, more than the combined share from all of Africa (six percent), Latin America and the Caribbean (seven percent), and Oceania (less than two percent). And global diagnoses are only expected to increase, reaching 35million a year by 2050. Lung cancer was the most commonly diagnosed among both men and women, responsible for almost 2.5 million new cases, or one in eight cancers worldwide. In the US, an estimated 236,740 new cases of lung cancer were diagnosed, and 130,000 people died. Breast cancer in women made up 12 percent of cases worldwide, colorectal accounted for 10 percent, prostate at seven percent, and stomach at five percent. Cancer is now the leading cause of death in Americans under 85, according to the American Cancer Society's 2024 report. While it remains the second-leading cause of death overall in the US, it has surpassed heart disease as the top killer in younger age groups. The anticipated spike in new cancer diagnoses is mainly due to population growth and aging, but experts are increasingly blaming environmental toxins and ultra-processed foods. And though cancer rates among people under 50 are on the rise, particularly colorectal cancer, the disease still primarily afflicts seniors. 'This rise in projected cancer cases by 2050 is solely due to the aging and growth of the population, assuming current incidence rates remain unchanged,' Dr Hyuna Sung, senior principal scientist at the American Cancer Society, said. 'Notably, the prevalence of major risk factors such as consumption of unhealthy diet, physical inactivity, heavy alcohol consumption, and cigarette smoking are increasing in many parts of the world and will likely exacerbate the future burden of cancer barring any large scale interventions.' Experts warn that the projected rise in cancer cases by 2050 stems from more than just aging populations. Population growth explains part of the increase, but preventable risk factors —poor diet, lack of access to screenings, and chemical exposures — are also driving the disproportionate spikes. While the US diagnoses about one in six global cancer cases, it accounts for just seven percent of deaths worldwide, thanks to advanced treatments and fast drug approvals. The American Cancer Society reported that almost half of all cases and about 56 percent of cancer deaths in 2022 occurred in Asia, where over 59 percent of the world's population lives. Cancer death rates in Africa and Asia are much higher than cases, partly because cancers there are often found late and are harder to treat. Europe has more cancer cases and deaths than expected for its population, making up about 20 percent of global cases and deaths, though it has less than 10 percent of the world's people. Prostate cancer in men is the most frequently diagnosed cancer in 118 countries, followed by lung cancer among both sexes in 33 countries, and liver, colorectal, and stomach cancer ranking in first place in 11, nine, and eight countries, respectively. By 2050, lung cancer cases will climb from about 2.5 million in 2022 to roughly four million. Deaths will also climb from approximately 1.8 million to about three million. Global breast cancer cases are projected to surge from 2.3 million to 3.5 million by 2050, with deaths rising from 666,000 to 1 million. Breast cancer is the most common cancer in women (excluding skin cancer), diagnosed in 157 countries, while cervical cancer leads in 25 others. The US saw 288,000 new cases in 2022, with over 319,000 projected for 2025. Just 10 cancer types cause over 60 percent of all cases and deaths globally. Leading the pack is lung cancer (12.4 percent of cases), followed by breast (11.6 percent), colorectal (9.6 percent), prostate (7.3 percent), and stomach cancers (4.9 percent). Colorectal cancer cases will skyrocket from 1.9 million to 3 million globally by 2050, fueled by processed diets and rising early-onset cases. In 2023, 19,550 Americans under 50 were diagnosed with CRC. Deaths will climb from 904,000 to 1.4 million, especially in regions with poor screening. In North America, pancreatic cancer cases and deaths will both increase sharply, with minimal survival improvements expected. Obesity and diabetes are key drivers. Prostate cancer is set to explode—from 1.5 million cases today to a staggering 2.5 million by 2050—as the world's population ages. Deaths will leap from 397,000 to 600,000, hitting sub-Saharan Africa hardest, where life-saving treatments remain out of reach for millions. Liver cancer cases will rise from 865,000 to 1.2 million. Deaths will remain high, nearing one million, due to late detection in poorer parts of the world. It's on track to become more common, fueled by America's growing struggles with obesity, diabetes, and heavy drinking—even as hepatitis-linked cases fade. Deaths will climb in lockstep, as most patients are diagnosed too late for effective treatment. Cervical cancer cases could plummet from 660,000 to 500,000 with wider HPV vaccination, yet deaths may persist in Africa without better screening. Meanwhile, North America could nearly eliminate it, thanks to vaccines and early detection. Stomach cancer cases will decline slightly due to H. pylori control, but deaths will persist in regions with limited healthcare. Pancreatic cancer cases will spike from 511,000 to 800,000, with deaths mirroring this rise due to poor survival rates. Esophageal cancer cases will grow from 511,000 to 700,000, driven by obesity-related adenocarcinoma in wealthy nations. While cases in the US are rising, deaths due to cancer are on the decline thanks to advances in treatments. Scientists can now engineer immune cells in the lab that target and kill cancer cells, while CRISPR-based gene therapies have progressed from the lab to clinical trials for people with cancer. Dr Karen E Knudsen, CEO of the American Cancer Society, said: 'Understanding the global cancer burden is critical to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. 'This data provides insight into trends and potential areas for intervention and can help prioritize discovery efforts worldwide.
Reuters
an hour ago
- Reuters
UnitedHealth appoints new CEO to run health services division
NEW YORK, June 26 (Reuters) - UnitedHealth Group's (UNH.N), opens new tab health services segment, Optum Health, will be led by Patrick Conway, according to an internal company memo. A spokesperson for UnitedHealth said Conway's experience in value-based care, where payment is generated from keeping patients healthy, drove the health insurer's new appointment. 'Leadership changes are consistent with the company's longstanding, intentional approach to develop an executive team with a range of experiences across its diverse portfolio of businesses," the spokesperson said. The company named former Optum Health CEO Amar Desai as vice-chairman of the unit. UnitedHealth Group named a new company-wide CEO, veteran Stephen Hemsley, to steer the healthcare giant following its first earnings miss since 2008. Conway in April was appointed CEO of UnitedHealth's Optum segment, which operates its Optum Health unit, and previously ran its Optum Rx pharmacy benefit manager. Optum Health, which operates medical clinics and offers nursing services, serves as UnitedHealth's healthcare delivery arm. In a first-quarter earnings call, UnitedHealth detailed underperforming revenue at Optum Health, citing reduced engagement from Medicare Advantage patients. A May Wall Street Journal report detailed a criminal probe by the Department of Justice on UnitedHealth's billing practices, related to in-home visits it conducts within Optum Health. Hemsley in a June shareholder meeting said that the company was undertaking a review of practices across its business, apologizing for recent underperformance in earnings.
Telegraph
an hour ago
- Telegraph
Boots and Specsavers to take over NHS care
Companies such as Boots and Specsavers will offer more NHS care under plans to shift services onto the high street. Wes Streeting said a 10-year health plan would set out a much greater role for private companies in carrying out checks normally done in hospital. The Health Secretary also said shifting care out of hospitals into the community would mean more services in shopping areas, close to people's homes, to make them more convenient. Mr Streeting said: 'There's definitely a role for high street players like Boots and Specsavers to help cut NHS waiting lists and to help provide great care and services and advice to patients as part of the wider primary care team.' Under the plans, GPs will take a bigger role leading neighbourhood health services, which could bring a range of services together. This could result in pharmacies offering a wider range of checks and services, and high street opticians carrying out assessments and diagnostics for common eye conditions, he suggested. Mr Streeting said the plans would aim to create 'a real partnership between GPs and other parts of the primary care system' – instead of them scrapping over resources. He said the shift away from hospitals would see more NHS services, including those run directly by the NHS, on the high street. Last year the NHS launched a scheme that means people can consult pharmacists about seven common conditions – including sore throats, earache and urinary tract infections – instead of having to make an appointment with a doctor. Health officials are looking to expand the role of pharmacists further, dealing with a wider range of conditions, relieving pressures on GP surgeries. Hospitals could also take over the running of GP practices, as part of efforts to improve access to care across neighbourhoods. Last week the Health Secretary said he would not shrink from leaning more heavily on the private sector to improve access to NHS care. Wes Streeting said he 'refused to be bound by outdated ideological battles', saying using independent hospitals to provide taxpayer-funded care did not contradict the principles of the health service. Writing for The Telegraph he said he would fight for the future of the NHS, warning of a 'national emergency' facing the country. Mr Streeting made the comments as new figures showed that almost 1.4 million people have had private care on the NHS since Labour won the election. Next week he will launch a 10-year plan for the NHS, which promises three major shifts – from hospital to community, from analogue to digital and from treating sickness to prevention, with private sector involvement expected to play a key role. Elsewhere under the plans, patients will be able to refer themselves for therapy through the NHS app. Instead of having to turn to costly mental health apps, the NHS app 'offers a free service built by trusted clinicians', according to a spokesman. Some 6,700 more mental health workers have been recruited since July 2024. Mr Streeting said: 'Not getting the right support for your mental health isn't just debilitating, it can hit a painful pause button on your life – stopping you working, enjoying time with family and friends, or living day-to-day life. 'Patients have faced the crisis of access to mental health services for far too long, and this Government is determined to change that through our Plan for Change to rebuild the NHS. 'That's why we're putting digital front doors on mental health services for patients up and down the country and harnessing technology to provide 24-hour care. And we're creating more opportunities for support not just through the NHS App but through care in your community too. 'We are already over halfway towards our target of recruiting 8,500 extra mental health workers, and through our upcoming 10 year health plan we will get more people back to health and back to work.'
